Drug
Riociguat (BAY63-2521)
Riociguat (BAY63-2521) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph phase_1
1
25%
Ph phase_2
2
50%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)
Trials by Status
completed250%
withdrawn125%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
NCT00863681
completedphase_1
Relative Bioavailability and Food Effect Study
NCT01489488
terminatedphase_2
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
NCT01172756
withdrawnphase_2
Coronary Vasomotor Response After Riociguat Exposure
NCT01165931
Clinical Trials (4)
Showing 4 of 4 trials
NCT00863681Phase 3
BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
NCT01489488Phase 1
Relative Bioavailability and Food Effect Study
NCT01172756Phase 2
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Diastolic Dysfunction
NCT01165931Phase 2
Coronary Vasomotor Response After Riociguat Exposure
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4